Tumor-specific vector for gene therapy
US7351697B2 · kind B2 · utility
2Cited by
3References
20Claims
0Family size
Inventors
Key dates
| Filing date | Jul 21, 2005 |
| Grant date | Apr 1, 2008 |
| Priority date | — |
| Expiry date | Jul 21, 2025 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2830/008
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to a vector for the gene therapeutic treatment of tumors, especially in connection with radiotherapy. Said vector is provided with a therapeutic gene in the DNA sequence thereof. The gene is controlled by the promoter for the catalytic subunit of the telomerase or by the promoter for cyclin A.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.